Epizyme's Soft Tissue Cancer Drug Granted Speedy FDA Approval

EPIZYME'S SOFT TISSUE CANCER DRUG GRANTED SPEEDY FDA APPROVAL

Epizyme won accelerated FDA approval Thursday for a drug developed to treat the rare cancer epithelioid sarcoma. The regulatory decision...

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

AFTER ASTRAZENECA, OSBOURN REFLECTS ON ROLES AT CAT & MEDIMMUNE

MedImmune, AstraZeneca's biologics division, is no more. The pharmaceutical giant announced last year that the name would be retired...

 
 
 
FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

FDA FLAGS RISK OF INFECTION, KIDNEY DAMAGE FOR SAREPTA DUCHENNE DRUGS

Safety concerns stymied Sarepta Therapeutics' attempt to win FDA approval last August for golodirsen , its second Duchenne muscular...

CEOs of Women's Health Companies Fight to Open Investment Floodgates

CEOS OF WOMEN'S HEALTH COMPANIES FIGHT TO OPEN INVESTMENT FLOODGATES

Talking about sex with potential investors? For EvoFem Biosciences CEO Saundra Pelletier, it's the first item on the docket. Her company...

 
 
 
Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

EMENDO EYES THE CLINIC FOR CRISPR THERAPY THAT MAKES SINGLE-GENE EDITS

CRISPR gene editing offers the potential to selectively edit the genetic mutations causing inherited diseases, but Emendo Biotherapeutics...

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

HORIZON GETS EARLY FDA OK FOR FIRST THYROID EYE DISEASE TREATMENT

The first treatment for a rare disease that causes eye bulging and double vision received an FDA nod on Tuesday, weeks ahead of the...

 
 
 
After Ending Cancer Drug Program, Halozyme Predicts Profits in 2020

AFTER ENDING CANCER DRUG PROGRAM, HALOZYME PREDICTS PROFITS IN 2020

Halozyme suffered a setback in November when its investigational pancreatic drug failed a Phase 3 clinical trial , but its CEO says...

Of Science and Sea Urchins: Researchers Plumb Oceans for Biological Insights

OF SCIENCE AND SEA URCHINS: RESEARCHERS PLUMB OCEANS FOR BIOLOGICAL INSIGHTS

The ocean is home to more biodiversity than anywhere else on the planet-making it a largely untapped source of opportunity for researchers...

 
 
 
Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

BIO ROUNDUP: EQRX'S AMBITIONS, NEKTAR NO VOTE, NEW FRAZIER FUND & MORE

Perhaps the most talked-about news at the JP Morgan Healthcare Conference this week was a new startup that launched with $200 million...

 
 
 
Mayo Clinic Joins $60M Financing for Biomedical Software Firm nference

MAYO CLINIC JOINS $60M FINANCING FOR BIOMEDICAL SOFTWARE FIRM NFERENCE

Startup nference has closed a $60 million Series B financing round to expand the use of its augmented intelligence platform in clinical...

Event Announcement: Xcelerating Life Sciences San Diego

EVENT ANNOUNCEMENT: XCELERATING LIFE SCIENCES SAN DIEGO

We're excited to announce the first in Xconomy's new Xcelerating Life Sciences event series convening local communities of innovators,...

 
 
 
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal

CANCER DRUG DEVELOPER BIONTECH TO BUY NEON THERAPEUTICS IN $67M DEAL

Neon Therapeutics closed 2019 by curtailing its cancer vaccine programs and laying off 24 percent of its workforce, part of a corporate...

Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D

EMENDO BIOTHERAPEUTICS NABS $61M FOR “NEXT-GENERATION CRISPR” R&D

Emendo Biotherapeutics, a company aiming to apply CRISPR gene editing to a wider range of genetic diseases, has raised $61 million...

 
 
 
Phage Therapy Firm APT Lands DoD Contract for Antibiotic Alternative

PHAGE THERAPY FIRM APT LANDS DOD CONTRACT FOR ANTIBIOTIC ALTERNATIVE

The Department of Defense has awarded Adaptive Phage Therapeutics a $10.2 million contract to help advance its experimental therapy...

 
 
 
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery

PFIZER TAPS INSILICO MEDICINE TO USE AI FOR DRUG TARGET DISCOVERY

Insilico Medicine on Tuesday announced that it has entered a research collaboration with Pfizer, which Insilico CEO Alex Zhavoronkov...

 
 
 
Daré Bioscience Inks Deal With Bayer for Non-Hormonal Contraceptive

DARÉ BIOSCIENCE INKS DEAL WITH BAYER FOR NON-HORMONAL CONTRACEPTIVE

Daré Bioscience launched in 2015 with the aim of assembling a portfolio of novel women's health products intended to pique interest...

 
 
 



World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Q&A With Eric Seaborg: Science Writer, Author, and Outdoorsman

Q&A With Eric Seaborg: Science Writer, Author, and Outdoorsman

Eric Seaborg Eric Seaborg, a writer and author, outdoorsman and environmentalist, has a love for hiking that he shared with his father, the late chemist and Nobel laureate... Read more ...

Project to Rapidly Sequence Maize Pangenome Delivers Publicly Available Resource

Project to Rapidly Sequence Maize Pangenome Delivers Publicly Available Resource

Matt Hufford, associate professor at Iowa State University, helped produce a 26-line maize pangenome assembly collection Maize researchers have been rejoicing over a New Year's... Read more ...

Epizyme's Soft Tissue Cancer Drug Granted Speedy FDA Approval

Epizyme's Soft Tissue Cancer Drug Granted Speedy FDA Approval

Epizyme won accelerated FDA approval Thursday for a drug developed to treat the rare cancer epithelioid sarcoma. The regulatory decision for the Epizyme drug, tazemetostat... Read more ...

The Wuhan Coronavirus Inspires a Look Back at the Discovery of Viruses

The Wuhan Coronavirus Inspires a Look Back at the Discovery of Viruses

I'm astonished at the speed with which geneticists and epidemiologists are zeroing in on the Wuhan coronavirus. Nomenclature is still up in the air. The first name, “2019-nCoV”... Read more ...

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

MedImmune, AstraZeneca's biologics division, is no more. The pharmaceutical giant announced last year that the name would be retired as part of a research and development... Read more ...

FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

Safety concerns stymied Sarepta Therapeutics' attempt to win FDA approval last August for golodirsen , its second Duchenne muscular dystrophy drug. But an appeal of the... Read more ...

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

The first treatment for a rare disease that causes eye bulging and double vision received an FDA nod on Tuesday, weeks ahead of the agency's March 8 deadline to review the... Read more ...

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

CRISPR gene editing offers the potential to selectively edit the genetic mutations causing inherited diseases, but Emendo Biotherapeutics CEO David Baram contends it's not... Read more ...

CEOs of Women's Health Companies Fight to Open Investment Floodgates

CEOs of Women's Health Companies Fight to Open Investment Floodgates

Talking about sex with potential investors? For EvoFem Biosciences CEO Saundra Pelletier, it's the first item on the docket. Her company recently submitted Amphora, a... Read more ...

Bachem: EHS Coordinator

Bachem: Your Responsibilities The Environmental, Health and Safety Coordinator will be responsible for providing full time environmental health and sa Vista, CA, US ... Read more ...